Assuntos
Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/complicações , Infarto/imunologia , Adulto , Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/tratamento farmacológico , Glucocorticoides/administração & dosagem , Humanos , Fatores Imunológicos/administração & dosagem , Infarto/diagnóstico por imagem , Masculino , Prednisolona/administração & dosagem , Rituximab/administração & dosagemRESUMO
RATIONALE: Anti-angiotensin II type 1 receptor antibodies (AT1R-Abs) have been demonstrated to increase the risk of antibody-mediated rejection. We report a case of AT1R-Ab mediated rejection which caused early critical cortical infarction. PATIENT CONCERNS: A 52-year-old man with end-stage kidney disease underwent preemptive kidney transplantation (KT) from his wife. He had no immunologic risk except ABO incompatibility. Proper desensitization treatment were applied prior to KT. On postoperative day 1, he showed stable clinical course with adequate urine output, but there was no decrease in serum creatinine level and imaging studies showed hypoperfusion in the transplanted kidney. DIAGNOSES: Allograft biopsy revealed total cortical infarction with severe necrotizing vasculitis, but the medullary area was preserved. Serum AT1R-Ab concentration was elevated from 10.9âU/mL before KT to 19.1âU/mL on 7âdays after KT. INTERVENTIONS: He was treated with plasmapheresis, intravenous immunoglobulin, rituximab, high-dose methylprednisolone, and bortezomib. OUTCOMES: The treatment showed a partial response, and he was discharged with 7.3âmg/dL creatinine level. At 4âmonths, his creatinine plateaued at 5.5âmg/dL and AT1R-Ab decreased to 3.6âU/mL. LESSONS: This case highlights the risk of early active antibody-mediated rejection by preformed AT1R-Ab, suggesting its ability to exhibit atypical histopathologic findings, such as total cortical infarction.
Assuntos
Rejeição de Enxerto/imunologia , Infarto/imunologia , Isoanticorpos/sangue , Necrose do Córtex Renal/imunologia , Transplante de Rim/efeitos adversos , Receptor Tipo 1 de Angiotensina/imunologia , Aloenxertos/irrigação sanguínea , Aloenxertos/imunologia , Aloenxertos/patologia , Feminino , Rejeição de Enxerto/sangue , Rejeição de Enxerto/diagnóstico , Rejeição de Enxerto/terapia , Teste de Histocompatibilidade , Humanos , Fatores Imunológicos/administração & dosagem , Infarto/sangue , Infarto/diagnóstico , Infarto/terapia , Isoanticorpos/imunologia , Córtex Renal/irrigação sanguínea , Córtex Renal/imunologia , Córtex Renal/patologia , Necrose do Córtex Renal/sangue , Necrose do Córtex Renal/diagnóstico , Necrose do Córtex Renal/terapia , Falência Renal Crônica/cirurgia , Doadores Vivos , Masculino , Pessoa de Meia-Idade , Plasmaferese , Cônjuges , Fatores de TempoRESUMO
Renal biopsy is useful to better understand the histological pattern of a lesion (glomerular, tubulointerstitial, and vascular) and the pathogenesis that leads to kidney failure. The potential impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the kidneys is still undetermined, and a variety of lesions are seen in the kidney tissue of coronavirus disease patients. This review is based on the morphological findings of patients described in case reports and a series of published cases. A search was conducted on MEDLINE and PubMed of case reports and case series of lesions in the presence of non-critical infection by SARS-CoV-2 published until 15/09/2020. We highlight the potential of the virus directly influencing the damage or the innate and adaptive immune response activating cytokine and procoagulant cascades, in addition to the genetic component triggering glomerular diseases, mainly collapsing focal segmental glomerulosclerosis, tubulointerstitial, and even vascular diseases. Kidney lesions caused by SARS-CoV-2 are frequent and have an impact on morbidity and mortality; thus, studies are needed to assess the morphological kidney changes and their mechanisms and may help define their spectrum and immediate or long-term impact.
Assuntos
Injúria Renal Aguda/patologia , COVID-19/patologia , Glomerulonefrite/patologia , Rim/patologia , Microangiopatias Trombóticas/patologia , Injúria Renal Aguda/sangue , Injúria Renal Aguda/imunologia , Imunidade Adaptativa/imunologia , Arteriosclerose/imunologia , Arteriosclerose/patologia , COVID-19/sangue , COVID-19/imunologia , Citocinas/imunologia , Glomerulonefrite/imunologia , Glomerulonefrite por IGA/imunologia , Glomerulonefrite por IGA/patologia , Glomerulosclerose Segmentar e Focal/imunologia , Glomerulosclerose Segmentar e Focal/patologia , Humanos , Imunidade Inata/imunologia , Infarto/imunologia , Infarto/patologia , Rim/irrigação sanguínea , Rim/imunologia , Necrose do Córtex Renal/imunologia , Necrose do Córtex Renal/patologia , Nefrite Intersticial/imunologia , Nefrite Intersticial/patologia , Nefrose Lipoide/imunologia , Nefrose Lipoide/patologia , Rabdomiólise , SARS-CoV-2 , Trombofilia/sangue , Microangiopatias Trombóticas/imunologiaAssuntos
Hospedeiro Imunocomprometido , Infarto/etiologia , Intestinos/irrigação sanguínea , Mucormicose/complicações , Enterite/complicações , Enterite/diagnóstico , Enterite/microbiologia , Humanos , Infarto/diagnóstico , Infarto/imunologia , Infarto/microbiologia , Intestinos/microbiologia , Intestinos/patologia , Leucemia Mieloide Aguda/complicações , Leucemia Mieloide Aguda/imunologia , Leucemia Mieloide Aguda/microbiologia , Masculino , Pessoa de Meia-Idade , Mucormicose/diagnóstico , Mucormicose/imunologiaRESUMO
PROBLEM: The lectin pathway of the complement system may be involved in the pathogenesis of pre-eclampsia. We aimed to investigate changes in serum concentrations of a broad range of lectin pathway proteins during normal pregnancy and their association with pre-eclampsia, placental infarctions and intrauterine growth restriction (IUGR). METHOD OF STUDY: We included 51 women with normotensive pregnancies and 54 women with pregnancies complicated by pre-eclampsia. Blood samples were obtained at gestational weeks 16, 33, 37, and after delivery for the normotensive pregnant women and before and after delivery for women with pre-eclampsia. Mannose-binding lectin (MBL), H- and M-ficolin, collectin liver-1 (CL-L1), MBL-associated serine protease (MASP)-1, MASP-2 and MASP-3 and MBL-associated proteins of 19 (MAp19) and 44 (MAp44) kDa were analysed. Clinical information was obtained from medical records. The placentae were examined by two experienced perinatal pathologists. RESULTS: Lectin pathway protein concentrations generally increased during normal pregnancy and decreased after delivery in both normotensive pregnant women and women with pre-eclampsia. Exceptions were MASP-3 which increased after delivery in both groups (P < 0.0001) and H-ficolin which increased after delivery in pre-eclampsia (P < 0.0001). H-ficolin (P < 0.0001), M-ficolin (P = 0.005) and MASP-3 (P = 0.03) concentrations were lower in women with pre-eclampsia than in normotensive pregnant women. Low MASP-3 concentrations were associated with placental infarction (P = 0.03) and IUGR (P = 0.04). Low H-ficolin concentrations were associated with IUGR (P < 0.01). CONCLUSION: In general, lectin pathway protein serum concentrations increased during normal pregnancy. H-ficolin and MASP-3 may be involved in the pathophysiology of pre-eclampsia and IUGR and could be potential future pre-eclampsia biomarkers.
Assuntos
Lectina de Ligação a Manose da Via do Complemento , Retardo do Crescimento Fetal/imunologia , Infarto/imunologia , Serina Proteases Associadas a Proteína de Ligação a Manose/metabolismo , Placenta/fisiologia , Pré-Eclâmpsia/imunologia , Adulto , Biomarcadores/sangue , Ativação do Complemento , Feminino , Humanos , Lectinas/sangue , Lectina de Ligação a Manose/sangue , Gravidez , FicolinasRESUMO
OBJECTIVES: Preeclampsia complicates 2-8% of all pregnancies. Studies on the association of preeclampsia with thrombophilia are conflicting. Clinical heterogeneity of the disease may be one of the explanations. The present study addresses the question whether different phenotypes of preeclampsia are associated with thrombophilia factors. Study design We planned a retrospective cohort study. From 1985 until 2010 women with preeclampsia were offered postpartum screening for the following thrombophilia factors: anti-phospholipid antibodies, APC-resistance, protein C deficiency and protein S deficiency, hyperhomocysteineamia, factor V Leiden and Prothrombin gene mutation. Hospital records were used to obtain information on phenotypes of the preeclampsia and placental histology. RESULTS: We identified 844 women with singleton pregnancies who were screened for thrombophilia factors. HELLP complicated 49% of pregnancies; Fetal growth restriction complicated 61% of pregnancies. Early delivery (<34th week) occurred in 71% of pregnancies. Any thrombophilia factor was present in 29% of the women. Severe preeclampsia was associated with protein S deficiency (p=0.01). Fetal growth restriction was associated with anti-phospholipid antibodies (p<0.01). Early onset preeclampsia was associated with anti-phospholipid antibodies (p=0.01). Extensive placental infarction (>10%) was associated with anti-phospholipid antibodies (p<0.01). Low placental weight (<5th percentile) was associated with hyperhomocysteineamia (p=0.03). No other associations were observed. CONCLUSIONS: Early onset preeclampsia, especially if complicated by fetal growth restriction, are associated with anti-phospholipid antibodies. Other phenotypes of preeclampsia, especially HELLP syndrome, were not associated with thrombophilia. We advise only to test for anti-phospholipid antibodies after early onset preeclampsia, especially if complicated by fetal growth restriction. We suggest enough evidence is presented to justify no further studies are needed.
Assuntos
Anticorpos Antifosfolipídeos/sangue , Infarto/imunologia , Pré-Eclâmpsia/imunologia , Trombofilia/sangue , Resistência à Proteína C Ativada/sangue , Adolescente , Adulto , Fator V/genética , Feminino , Retardo do Crescimento Fetal/imunologia , Síndrome HELLP/etiologia , Humanos , Hiper-Homocisteinemia/sangue , Mutação , Tamanho do Órgão , Fenótipo , Placenta/irrigação sanguínea , Placenta/patologia , Pré-Eclâmpsia/sangue , Gravidez , Deficiência de Proteína C/sangue , Protrombina/genética , Estudos Retrospectivos , Adulto JovemRESUMO
OBJECTIVE: Massive perivillous fibrin deposition (MPFD) and maternal floor infarction (MFI) are related placental lesions often associated with fetal death and fetal growth restriction. A tendency to recur in subsequent pregnancies has been reported. This study was conducted to determine whether this complication of pregnancy could reflect maternal antifetal rejection. METHODS: Pregnancies with MPFD were identified (n = 10). Controls consisted of women with uncomplicated pregnancies who delivered at term without MPFD (n = 175). Second-trimester maternal plasma was analyzed for panel-reactive anti-HLA class I and class II antibodies. The prevalence of chronic chorioamnionitis, villitis of unknown etiology, and plasma cell deciduitis was compared between cases and controls. Immunohistochemistry was performed on available umbilical vein segments from cases with MPFD (n = 4) to determine whether there was evidence of complement activation (C4d deposition). Specific maternal HLA-antibody and fetal HLA-antigen status were also determined in paired specimens (n = 6). Plasma CXCL-10 concentrations were measured in longitudinal samples of cases (n = 28 specimens) and controls (n = 749 specimens) by ELISA. Linear mixed-effects models were used to test for differences in plasma CXCL-10 concentration. RESULTS: (i) The prevalence of plasma cell deciduitis in the placenta was significantly higher in cases with MPFD than in those with uncomplicated term deliveries (40% versus 8.6%, P = 0.01), (ii) patients with MPFD had a significantly higher frequency of maternal anti-HLA class I positivity during the second trimester than those with uncomplicated term deliveries (80% versus 36%, P = 0.01); (iii) strongly positive C4d deposition was observed on umbilical vein endothelium in cases of MPFD, (iv) a specific maternal antibody against fetal HLA antigen class I or II was identified in all cases of MPFD; and 5) the mean maternal plasma concentration of CXCL-10 was higher in patients with evidence of MPFD than in those without evidence of MFPD (P < 0.001). CONCLUSION: A subset of patients with MPFD has evidence of maternal antifetal rejection.
Assuntos
Vilosidades Coriônicas/metabolismo , Morte Fetal/imunologia , Retardo do Crescimento Fetal/imunologia , Fibrina/metabolismo , Histocompatibilidade Materno-Fetal , Infarto/imunologia , Diafragma da Pelve/patologia , Placenta/imunologia , Adulto , Quimiocina CXCL1/sangue , Vilosidades Coriônicas/patologia , Complemento C4/metabolismo , Endotélio Vascular/imunologia , Endotélio Vascular/metabolismo , Feminino , Morte Fetal/etiologia , Retardo do Crescimento Fetal/etiologia , Antígenos HLA/imunologia , Humanos , Infarto/complicações , Isoanticorpos/sangue , Diafragma da Pelve/irrigação sanguínea , Gravidez , Adulto JovemRESUMO
C4d deposition is considered to be evidence of antibody-mediated rejection. This study was conducted to compare C4d immunoreactivity between villitis of unknown etiology (VUE) and cytomegaloviral placentitis. C4d immunohistochemistry was performed in cases with VUE (n = 16) and cytomegaloviral placentitis (n = 5). Distinct, linear C4d immunoreactivity along the syncytiotrophoblast was found in all VUE cases. In cytomegaloviral placentitis, the intensity of C4d immunoreactivity along the syncytiotrophoblast was not prominent, but cytoplasmic C4d immunoreactivity of villous cytotrophoblasts was frequently observed. Further screening of the cases with placental infarcts (n = 5) demonstrated prominent C4d immunoreactivity in the chorionic villi adjacent to the infarct. We report the characteristic co-localization of VUE and C4d immunoreactivity. The overall findings in this study strongly suggest that the complement activation is a common mechanism of diverse placental injuries associated with rejection, infection, and ischemia.
Assuntos
Complemento C4b/análise , Infecções por Citomegalovirus/imunologia , Inflamação/imunologia , Fragmentos de Peptídeos/análise , Doenças Placentárias/imunologia , Placenta/imunologia , Adulto , Vilosidades Coriônicas/imunologia , Ativação do Complemento , Feminino , Humanos , Infarto/imunologia , Placenta/irrigação sanguínea , Doenças Placentárias/virologia , Gravidez , Trofoblastos/imunologiaRESUMO
We report on a male patient who tested positive for antiphospholipid antibodies for 43 years without thromboembolic manifestation of antiphospholipid syndrome (APS). He has been followed up in a prospective cohort study since 2001. Following his second hip replacement surgery, the patient developed acute adrenal failure due to bilateral hemorrhagic infarction. Prophylactic anticoagulation, surgery, or an immunological reaction to blood transfusion may have triggered this late and unusually located primary manifestation of APS in our patient.
Assuntos
Glândulas Suprarrenais/irrigação sanguínea , Síndrome Antifosfolipídica/complicações , Infarto/etiologia , Idoso , Anticorpos Antifosfolipídeos , Síndrome Antifosfolipídica/imunologia , Humanos , Infarto/imunologia , MasculinoRESUMO
Cold agglutinin disease occurring with cryoglobulinemia is a rare occurrence. Here, we report a patient with mixed cryoglobulinemia that was treated with rituximab and, after response, developed an anti-Pr cold agglutinin that manifested with hemolysis and microvascular occlusion causing mesenteric ischemia and cerebral infarction. Unlike previous reports of patients with cryoglobulinemia and cold agglutinin disease, our patient did not have a detectable cryoprecipitate when his cold agglutinin manifested.
Assuntos
Anemia Hemolítica Autoimune/induzido quimicamente , Anticorpos Monoclonais/efeitos adversos , Autoanticorpos/imunologia , Antígenos de Grupos Sanguíneos/imunologia , Infarto Cerebral/etiologia , Crioglobulinas/imunologia , Imunoglobulina M/imunologia , Imunossupressores/efeitos adversos , Intestinos/irrigação sanguínea , Isquemia/etiologia , Insuficiência de Múltiplos Órgãos/etiologia , Anemia Hemolítica Autoimune/complicações , Anemia Hemolítica Autoimune/imunologia , Anemia Hemolítica Autoimune/terapia , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Murinos , Especificidade de Anticorpos , Infarto Cerebral/imunologia , Terapia Combinada , Evolução Fatal , Arterite de Células Gigantes/complicações , Arterite de Células Gigantes/tratamento farmacológico , Humanos , Imunossupressores/uso terapêutico , Infarto/etiologia , Infarto/imunologia , Intestinos/cirurgia , Isquemia/imunologia , Isquemia/cirurgia , Rim/irrigação sanguínea , Fígado/irrigação sanguínea , Masculino , Pessoa de Meia-Idade , Plasmaferese , Rituximab , Circulação Esplâncnica , Baço/irrigação sanguíneaRESUMO
We report a case of unusual extraintestinal yersiniosis in a 16-year-old girl with generalized microinfarctions of the bone and spleen. For the past 2 years she had been repeatedly admitted to our hospital with reactive arthritis, erythema nodosum and iridocyclitis of unknown aetiology. Ultrasound showed multiple round hypoechoic lesions in the spleen that were shown to have low T2 signal on MRI. MRI also showed disseminated nodular lesions of the skeleton that were low T1 and high T2 signal and demonstrated inhomogeneous contrast enhancement. The patient is currently in good health on low-dose nonsteroidal immunosuppressive therapy. This is a unique case of microinfarctions of the skeleton and spleen caused by a severe postinfectious autoimmune reaction following extraintestinal Yersinia enterocolitica infection.
Assuntos
Doenças Autoimunes/diagnóstico , Doenças Autoimunes/microbiologia , Osso e Ossos/irrigação sanguínea , Infarto/diagnóstico , Infarto/microbiologia , Baço/irrigação sanguínea , Yersiniose/complicações , Yersiniose/diagnóstico , Yersinia enterocolitica , Adolescente , Feminino , Humanos , Infarto/imunologia , Imageamento por Ressonância Magnética , Radiografia Abdominal , Yersiniose/imunologia , Yersinia enterocolitica/imunologiaAssuntos
Síndrome Antifosfolipídica/complicações , Infarto/imunologia , Fígado/irrigação sanguínea , Transtornos Puerperais/imunologia , Adulto , Síndrome Antifosfolipídica/diagnóstico por imagem , Feminino , Humanos , Infarto/diagnóstico por imagem , Gravidez , Tomografia Computadorizada por Raios XRESUMO
Metastatic renal cancer is responsive in some cases to immunotherapeutic agents. Indications for nephrectomy in the face of metastatic disease have traditionally included palliation of symptoms caused by the primary tumor, and nephrectomy combined with metastatectomy in patients with resectable metastases. Recent findings from a Southwest Oncology Group trial strongly suggest that cytoreductive nephrectomy, combined with immunotherapy, may also result in improved survival in patients with unresectable metastases.
Assuntos
Carcinoma de Células Renais/cirurgia , Imunoterapia , Neoplasias Renais/cirurgia , Nefrectomia , Carcinoma de Células Renais/imunologia , Carcinoma de Células Renais/secundário , Terapia Combinada , Humanos , Infarto/imunologia , Rim/irrigação sanguínea , Neoplasias Renais/imunologia , Neoplasias Renais/patologia , PrognósticoRESUMO
We report on a series of 3 patients who underwent fine-needle aspiration (FNA) for clinically apparent lymphadenopathy. In all 3 cases, a diagnosis of malignancy was rendered based on cytologic findings (two metastatic squamous-cell carcinomas and one melanoma). However, initial follow-up surgical pathology reported only "extensive coagulative necrosis, no viable tumor seen." Subsequent immunohistochemical stains (cytokeratins (AE1/AE3), HMB45, S100, and Melan A) demonstrated the presence of metastatic tumor in the area of infarction in each case, thus establishing the presence of metastatic tumor and correct interpretation of the initial FNA. We conclude, based on our own experience and a few previously reported cases, that total infarction of the lymph nodes following FNA can occur, and immunohistochemistry can be helpful in clinical management.
Assuntos
Biópsia por Agulha/efeitos adversos , Infarto/etiologia , Infarto/patologia , Linfonodos/patologia , Adulto , Feminino , Humanos , Imuno-Histoquímica , Infarto/imunologia , Linfonodos/imunologia , Doenças Linfáticas/patologia , Masculino , Pessoa de Meia-IdadeAssuntos
Anticorpos/imunologia , Centrômero/imunologia , Dedos/patologia , Dedos/fisiopatologia , Gangrena/imunologia , Gangrena/patologia , Infarto/imunologia , Infarto/patologia , Idoso , Idoso de 80 Anos ou mais , Feminino , Gangrena/fisiopatologia , Humanos , Infarto/fisiopatologia , Doença de Raynaud/complicações , Doença de Raynaud/imunologia , Escleroderma Sistêmico/complicações , Escleroderma Sistêmico/imunologiaRESUMO
The clinical associations of antiphospholipid antibodies (aPL) are well recognized but the mechanism(s) causing the production of these antibodies are not yet known. We demonstrated the induction of pathogenic aPL antibodies that caused intrauterine fetal death and transverse myelopathy due to spinal cord infarction in mice by immunization with foreign beta2GPI. We also induced aPL and anti-beta2-GPI in mice by immunization with PL-binding viral peptides and hypothesized that in APS patients, aPL may be induced by beta2GPI-like-PL-binding products of common human bacteria and viruses.
Assuntos
Anticorpos Antifosfolipídeos/imunologia , Síndrome Antifosfolipídica/etiologia , Autoantígenos/imunologia , Doenças Autoimunes/etiologia , Morte Fetal/etiologia , Glicoproteínas/imunologia , Mielite Transversa/etiologia , Fragmentos de Peptídeos/imunologia , Animais , Anticorpos Antifosfolipídeos/biossíntese , Anticorpos Monoclonais/imunologia , Especificidade de Anticorpos , Antígenos de Bactérias/imunologia , Antígenos Virais/imunologia , Síndrome Antifosfolipídica/imunologia , Autoantígenos/química , Doenças Autoimunes/imunologia , Reações Cruzadas , Modelos Animais de Doenças , Feminino , Morte Fetal/imunologia , Glicoproteínas/química , Humanos , Imunização , Infarto/etiologia , Infarto/imunologia , Camundongos , Mimetismo Molecular , Mielite Transversa/imunologia , Gravidez , Coelhos , Medula Espinal/irrigação sanguínea , Trombofilia/etiologia , Trombofilia/imunologia , beta 2-Glicoproteína IRESUMO
Antineutrophil cytoplasmic antibody (ANCA)-associated disease (AAD) constitutes a pathological disease spectrum of a necrotizing vasculitis of small- and medium-sized vessels, extravascular granuloma formation, and necrotizing and crescentic glomerulonephritis, and also a clinical disease continuum which ranges from renal-limited disease to a widespread systemic vasculitis, including Wegener's granulomatosis and microscopic polyangiitis. In the latter, circulating ANCA are an aid to diagnosis and also may play a pathogenic part. Two contrasting patients with AAD are described, both of whom presented primary with dermatological features. These included a cutaneous purpuric vasculitis, orogenital ulceration, infarction of the fingertip, and pyoderma gangrenosum-like ulceration. These cases will familiarize dermatologists with both the concept and dermatological features of AAD.
Assuntos
Autoanticorpos/análise , Doenças Autoimunes/imunologia , Dermatopatias/imunologia , Anticorpos Anticitoplasma de Neutrófilos , Doenças Autoimunes/patologia , Dedos/irrigação sanguínea , Humanos , Vasculite por IgA/imunologia , Infarto/imunologia , Masculino , Pessoa de Meia-Idade , Pioderma Gangrenoso/imunologia , Dermatopatias/patologiaRESUMO
Ischemic injury is an important cause of functional derangement in the kidney. The complement (C) system has previously been shown to be an important mediator of ischemic tissue injury in myocardial infarction. In the present study we therefore investigated the possible role of C in renal ischemic lesions. The deposition and distribution of various C components (C1q, C3c, C3d, C4, C5, C6, C9) and regulators [vitronectin, clusterin and protectin (CD59)] in human renal infarction lesions were studied by indirect immunofluorescence microscopy. Deposition of components of the terminal C complex (TCC), as well as vitronectin and clusterin, were observed throughout the infarcted areas. The strongest deposits were seen on the membranes of tubular epithelial cells and in the tubular lumina of the infarction areas, especially in the border zone between normal and infarcted tissue. Using markers for different segments of tubuli (Tamm-Horsfall glycoprotein and brush border antigens) it was possible to localize deposits of TCC predominantly to the proximal tubuli. In the glomeruli of the infarcted areas deposits of TCC were seen as a crescent-like pattern at and immediately beneath the Bowman's capsule. The expression of cell membrane-associated protectin was diminished in tubular epithelial cells of the infarction lesions. A clue for the possible mechanism of C activation in renal infarction was obtained from in vitro experiments, in which the contact of normal human serum with urine was observed to lead to the generation of TCC.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Ativação do Complemento , Infarto/imunologia , Rim/irrigação sanguínea , Humanos , Técnicas Imunoenzimáticas , Imuno-Histoquímica , Técnicas In Vitro , Infarto/patologia , Rim/imunologia , Rim/patologia , Microscopia de Fluorescência , UrinaRESUMO
An 18-year-old woman developed acute congestive hepatic infarction in the presence of a circulating anticardiolipin antibody. She subsequently developed nodular regenerative hyperplasia of the liver (NRHL) with associated portal hypertension. Unlike previously reported cases of NRHL, this case offers a prospective follow-up of the development of NRHL. Its occurrence following an episode of hepatic venous impairment in an otherwise normal liver supports the hypothesis that NRHL may develop as a consequence of diminished hepatic venous drainage.
Assuntos
Anticorpos Anticardiolipina , Infarto/imunologia , Fígado/irrigação sanguínea , Fígado/patologia , Adulto , Biópsia , Feminino , Humanos , Hiperplasia/imunologia , Hipertensão Portal , Infarto/patologia , RecidivaRESUMO
We describe a patient with previous venous thrombosis while using oral contraceptives and recurrent pregnancy loss, who presented with massive hepatic infarction in the last trimester of the fourth gestation. Thrombocytopenia, the lupus anticoagulant (LA) and the anticardiolipin antibody (aCL) were detected and a diagnosis of a 'primary' antiphospholipid syndrome (APS) was made. The clinical and histological manifestations and the differential diagnosis, especially with DIC and pre-eclampsia, are discussed.